MedTrace Logo

Propacetamol to Reduce Post Cesarean Section Uterine Contraction Pain

NCT03878082 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-03-15

No results posted yet for this study

Summary

To evaluate that perioperative regular usage of propacetamol to reduce post cesarean section uterine contraction pain and opioid consumption

Conditions

  • Uterine Pain

Interventions

DRUG

Propacetamol 1g

pain control with IVPCA and propacetamol 1g every 6 hours for 2 days

DRUG

Propacetamol 2g

pain control with IVPCA and propacetamol 2g every 6 hours for 2 days

DRUG

IVPCA

pain control with IVPCA

Sponsors & Collaborators

  • Mackay Memorial Hospital

    lead OTHER

Principal Investigators

  • Chien-Chung Huang, MD · Mackay Memorial Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-12
Primary Completion
2022-12-30
Completion
2022-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03878082 on ClinicalTrials.gov